Cargando…

Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018

BACKGROUND: Given the ongoing opioid crisis in the United States (US), we investigated the opioid situation in Europe. The aims of the study are to provide an overview of trends in prescription opioid (PO) use and opioid-related adversities between 2010 and 2018 for different opioids in 19 European...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierce, Mimi, van Amsterdam, Jan, Kalkman, Gerard A., Schellekens, Arnt, van den Brink, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316471/
https://www.ncbi.nlm.nih.gov/pubmed/34165059
http://dx.doi.org/10.1192/j.eurpsy.2021.2219
_version_ 1783729859636232192
author Pierce, Mimi
van Amsterdam, Jan
Kalkman, Gerard A.
Schellekens, Arnt
van den Brink, Wim
author_facet Pierce, Mimi
van Amsterdam, Jan
Kalkman, Gerard A.
Schellekens, Arnt
van den Brink, Wim
author_sort Pierce, Mimi
collection PubMed
description BACKGROUND: Given the ongoing opioid crisis in the United States (US), we investigated the opioid situation in Europe. The aims of the study are to provide an overview of trends in prescription opioid (PO) use and opioid-related adversities between 2010 and 2018 for different opioids in 19 European countries and to present a comparison with similar data from the US. METHODS: A multisource database study with national data from 19 European countries evaluating trends between 2010 and 2018 in (a) PO consumption, (b) high-risk (HR) opioid users, (c) opioid-related hospital admissions, (d) opioid-related overdose deaths, (e) opioid use disorder treatment entries, and (f) patients in opioid substitution therapy (OST). Within and between-country comparisons and comparisons with data from the US were made. RESULTS: There was considerable variation between European countries. Most countries showed increased PO consumption with the largest increase and the highest consumption in the United Kingdom (UK) compared to the rest of Europe and the US in 2018 (UK: 58,088 defined daily doses for statistical purposes/1000 population/day). In 2018, Scotland had the highest rates (per 100,000 population) of HR opioid users (16·2), opioid-related hospital admissions (118), opioid-related deaths (22·7), opioid use disorder treatment admissions (190), and OST patients (555) of all included European countries. These rates were similar or even higher than those in the US in 2018. Other countries with high rates of opioid-related adversities were Northern Ireland (synthetic and “other” opioids), Ireland (heroin and methadone), and England (all opioids). All other countries had no or little increase in opioid-related adversities. CONCLUSIONS: Apart from the British Isles and especially Scotland, there is no indication of an opioid crisis comparable to that in the US in the 19 European countries that were part of this study. More research is needed to identify drivers and develop interventions to stop the emerging opioid crisis in the UK and Ireland.
format Online
Article
Text
id pubmed-8316471
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-83164712021-08-06 Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018 Pierce, Mimi van Amsterdam, Jan Kalkman, Gerard A. Schellekens, Arnt van den Brink, Wim Eur Psychiatry Research Article BACKGROUND: Given the ongoing opioid crisis in the United States (US), we investigated the opioid situation in Europe. The aims of the study are to provide an overview of trends in prescription opioid (PO) use and opioid-related adversities between 2010 and 2018 for different opioids in 19 European countries and to present a comparison with similar data from the US. METHODS: A multisource database study with national data from 19 European countries evaluating trends between 2010 and 2018 in (a) PO consumption, (b) high-risk (HR) opioid users, (c) opioid-related hospital admissions, (d) opioid-related overdose deaths, (e) opioid use disorder treatment entries, and (f) patients in opioid substitution therapy (OST). Within and between-country comparisons and comparisons with data from the US were made. RESULTS: There was considerable variation between European countries. Most countries showed increased PO consumption with the largest increase and the highest consumption in the United Kingdom (UK) compared to the rest of Europe and the US in 2018 (UK: 58,088 defined daily doses for statistical purposes/1000 population/day). In 2018, Scotland had the highest rates (per 100,000 population) of HR opioid users (16·2), opioid-related hospital admissions (118), opioid-related deaths (22·7), opioid use disorder treatment admissions (190), and OST patients (555) of all included European countries. These rates were similar or even higher than those in the US in 2018. Other countries with high rates of opioid-related adversities were Northern Ireland (synthetic and “other” opioids), Ireland (heroin and methadone), and England (all opioids). All other countries had no or little increase in opioid-related adversities. CONCLUSIONS: Apart from the British Isles and especially Scotland, there is no indication of an opioid crisis comparable to that in the US in the 19 European countries that were part of this study. More research is needed to identify drivers and develop interventions to stop the emerging opioid crisis in the UK and Ireland. Cambridge University Press 2021-06-21 /pmc/articles/PMC8316471/ /pubmed/34165059 http://dx.doi.org/10.1192/j.eurpsy.2021.2219 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pierce, Mimi
van Amsterdam, Jan
Kalkman, Gerard A.
Schellekens, Arnt
van den Brink, Wim
Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018
title Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018
title_full Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018
title_fullStr Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018
title_full_unstemmed Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018
title_short Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018
title_sort is europe facing an opioid crisis like the united states? an analysis of opioid use and related adverse effects in 19 european countries between 2010 and 2018
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316471/
https://www.ncbi.nlm.nih.gov/pubmed/34165059
http://dx.doi.org/10.1192/j.eurpsy.2021.2219
work_keys_str_mv AT piercemimi iseuropefacinganopioidcrisisliketheunitedstatesananalysisofopioiduseandrelatedadverseeffectsin19europeancountriesbetween2010and2018
AT vanamsterdamjan iseuropefacinganopioidcrisisliketheunitedstatesananalysisofopioiduseandrelatedadverseeffectsin19europeancountriesbetween2010and2018
AT kalkmangerarda iseuropefacinganopioidcrisisliketheunitedstatesananalysisofopioiduseandrelatedadverseeffectsin19europeancountriesbetween2010and2018
AT schellekensarnt iseuropefacinganopioidcrisisliketheunitedstatesananalysisofopioiduseandrelatedadverseeffectsin19europeancountriesbetween2010and2018
AT vandenbrinkwim iseuropefacinganopioidcrisisliketheunitedstatesananalysisofopioiduseandrelatedadverseeffectsin19europeancountriesbetween2010and2018